Company intelligence / Profile preview
Towa International
Kadoma, Osaka, Japantowainternational.com ↗
- Ownership
- Private
- Employees
- ~930
- Development stage
- Commercial
01
Overview
Towa International is a pharmaceutical company focused on generic and value-added medicines with over 380 marketed drugs and 3 pipeline drugs. They recently received approval for manufacturing and marketing three ingredients and eight generic drug products, including Zonisamide OD Tablets and Micafungin Sodium for intravenous infusion in February 2024.
- Therapeutic areas
- OncologyMetabolic DisordersEndocrinologyPulmonologyImmunologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculestabletscapsulesinjectablespatcheseye drops
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
TIS Inc. (joint venture for T Square Solutions)
Beyond the preview
Go deeper on Towa International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Towa International.